APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gastro Esophageal Reflux Disease (GERD) Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gastro Esophageal Reflux Disease (GERD) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173994180326 December 2025196 pages

Choose your research edition.

Industry ResearchGastro Esophageal Reflux Disease (GERD) Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastro Esophageal Reflux Disease (GERD) Drug Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Gastro Esophageal Reflux Disease (GERD) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastro Esophageal Reflux Disease (GERD) Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastro Esophageal Reflux Disease (GERD) Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Gastro Esophageal Reflux Disease (GERD) Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gastro Esophageal Reflux Disease (GERD) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gastro Esophageal Reflux Disease (GERD) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastro Esophageal Reflux Disease (GERD) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gastro Esophageal Reflux Disease (GERD) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug include Addex Therapeutics, Aros Pharma, AstraZeneca, Plc., Medtronic, Takeda Pharmaceutical Company Limited, The Kroger Co., GlaxoSmithKline, Pfizer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gastro Esophageal Reflux Disease (GERD) Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gastro Esophageal Reflux Disease (GERD) Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gastro Esophageal Reflux Disease (GERD) Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gastro Esophageal Reflux Disease (GERD) Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Gastro Esophageal Reflux Disease (GERD) Drug Segment by Company

Addex Therapeutics

Aros Pharma

AstraZeneca, Plc.

Medtronic

Takeda Pharmaceutical Company Limited

The Kroger Co.

GlaxoSmithKline

Pfizer

Merck

Novartis AG

Gastro Esophageal Reflux Disease (GERD) Drug Segment by Type

H2 Receptor Antagonist

Proton Pump Inhibitor (PPi)

Antacids

Gastro Esophageal Reflux Disease (GERD) Drug Segment by Application

Clinic

Hospital

Medical Center

Others

Gastro Esophageal Reflux Disease (GERD) Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastro Esophageal Reflux Disease (GERD) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastro Esophageal Reflux Disease (GERD) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastro Esophageal Reflux Disease (GERD) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gastro Esophageal Reflux Disease (GERD) Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastro Esophageal Reflux Disease (GERD) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gastro Esophageal Reflux Disease (GERD) Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gastro Esophageal Reflux Disease (GERD) Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gastro Esophageal Reflux Disease (GERD) Drug Industry Trends Table 2. Gastro Esophageal Reflux Disease (GERD) Drug Industry Drivers Table 3. Gastro Esophageal Reflux Disease (GERD) Drug Industry Opportunities and Challenges Table 4. Gastro Esophageal Reflux Disease (GERD) Drug Industry Restraints Table 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Manufacturers Table 9. Global Gastro Esophageal Reflux Disease (GERD) Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Gastro Esophageal Reflux Disease (GERD) Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gastro Esophageal Reflux Disease (GERD) Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers, Product Type & Application Table 13. Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gastro Esophageal Reflux Disease (GERD) Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of H2 Receptor Antagonist Table 17. Major Manufacturers of Proton Pump Inhibitor (PPi) Table 18. Major Manufacturers of Antacids Table 19. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (K Units) Table 21. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2027-2032) & (K Units) Table 22. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2021-2026) Table 23. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2027-2032) Table 24. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2026) & (K Units) Table 26. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2027-2032) & (K Units) Table 27. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2021-2026) Table 28. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Medical Center Table 32. Major Manufacturers of Others Table 33. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (K Units) Table 35. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2027-2032) & (K Units) Table 36. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2021-2026) Table 37. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2027-2032) Table 38. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2026) & (K Units) Table 40. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2027-2032) & (K Units) Table 41. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2021-2026) Table 42. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2027-2032) Table 43. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2021-2026) & (K Units) Table 45. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2021-2026) Table 46. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026) & (K Units) Table 50. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2027-2032) & (K Units) Table 51. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026) & (K Units) Table 53. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2027-2032) & (K Units) Table 60. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2021-2026) Table 64. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2027-2032) Table 65. Addex Therapeutics Company Information Table 66. Addex Therapeutics Business Overview Table 67. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 69. Addex Therapeutics Recent Development Table 70. Aros Pharma Company Information Table 71. Aros Pharma Business Overview Table 72. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 74. Aros Pharma Recent Development Table 75. AstraZeneca, Plc. Company Information Table 76. AstraZeneca, Plc. Business Overview Table 77. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 79. AstraZeneca, Plc. Recent Development Table 80. Medtronic Company Information Table 81. Medtronic Business Overview Table 82. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 84. Medtronic Recent Development Table 85. Takeda Pharmaceutical Company Limited Company Information Table 86. Takeda Pharmaceutical Company Limited Business Overview Table 87. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 89. Takeda Pharmaceutical Company Limited Recent Development Table 90. The Kroger Co. Company Information Table 91. The Kroger Co. Business Overview Table 92. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 94. The Kroger Co. Recent Development Table 95. GlaxoSmithKline Company Information Table 96. GlaxoSmithKline Business Overview Table 97. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 99. GlaxoSmithKline Recent Development Table 100. Pfizer Company Information Table 101. Pfizer Business Overview Table 102. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 104. Pfizer Recent Development Table 105. Merck Company Information Table 106. Merck Business Overview Table 107. Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 109. Merck Recent Development Table 110. Novartis AG Company Information Table 111. Novartis AG Business Overview Table 112. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 114. Novartis AG Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Gastro Esophageal Reflux Disease (GERD) Drug Distributors List Table 118. Gastro Esophageal Reflux Disease (GERD) Drug Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Gastro Esophageal Reflux Disease (GERD) Drug Product Image Figure 2. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (2021-2032) & (K Units) Figure 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Gastro Esophageal Reflux Disease (GERD) Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. H2 Receptor Antagonist Image Figure 9. Proton Pump Inhibitor (PPi) Image Figure 10. Antacids Image Figure 11. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2021-2032) Figure 14. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Medical Center Image Figure 20. Others Image Figure 21. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2021-2032) Figure 24. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2021-2032) Figure 27. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2021-2032) Figure 34. Germany Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2021-2032) Figure 41. China Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Gastro Esophageal Reflux Disease (GERD) Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Gastro Esophageal Reflux Disease (GERD) Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • H2 Receptor Antagonist
  • Proton Pump Inhibitor (PPi)
  • Antacids
Applications
  • Clinic
  • Hospital
  • Medical Center
  • Others
Companies covered
  • Addex Therapeutics
  • Aros Pharma
  • AstraZeneca, Plc.
  • Medtronic
  • Takeda Pharmaceutical Company Limited
  • The Kroger Co.
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Dynamics
  1. 2.1 Gastro Esophageal Reflux Disease (GERD) Drug Industry Trends
  2. 2.2 Gastro Esophageal Reflux Disease (GERD) Drug Industry Drivers
  3. 2.3 Gastro Esophageal Reflux Disease (GERD) Drug Industry Opportunities and Challenges
  4. 2.4 Gastro Esophageal Reflux Disease (GERD) Drug Industry Restraints
3 Gastro Esophageal Reflux Disease (GERD) Drug Market by Manufacturers
  1. 3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gastro Esophageal Reflux Disease (GERD) Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers, Product Type & Application
  7. 3.7 Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gastro Esophageal Reflux Disease (GERD) Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gastro Esophageal Reflux Disease (GERD) Drug Tier 1, Tier 2, and Tier 3
4 Gastro Esophageal Reflux Disease (GERD) Drug Market by Type
  1. 4.1 Gastro Esophageal Reflux Disease (GERD) Drug Type Introduction
  2. 4.1.1 H2 Receptor Antagonist
  3. 4.1.2 Proton Pump Inhibitor (PPi)
  4. 4.1.3 Antacids
  5. 4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type
  6. 4.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2032)
  8. 4.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2021-2032)
  9. 4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type
  10. 4.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2032)
  12. 4.3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2021-2032)
5 Gastro Esophageal Reflux Disease (GERD) Drug Market by Application
  1. 5.1 Gastro Esophageal Reflux Disease (GERD) Drug Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Medical Center
  5. 5.1.4 Others
  6. 5.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application
  7. 5.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2032)
  9. 5.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2021-2032)
  10. 5.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application
  11. 5.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2032)
  13. 5.3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2021-2032)
6 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region
  1. 6.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region
  1. 7.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region
  2. 7.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032)
  8. 7.2.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032)
  11. 7.3.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Addex Therapeutics
  2. 8.1.1 Addex Therapeutics Company Information
  3. 8.1.2 Addex Therapeutics Business Overview
  4. 8.1.3 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  6. 8.1.5 Addex Therapeutics Recent Developments
  7. 8.2 Aros Pharma
  8. 8.2.1 Aros Pharma Company Information
  9. 8.2.2 Aros Pharma Business Overview
  10. 8.2.3 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  12. 8.2.5 Aros Pharma Recent Developments
  13. 8.3 AstraZeneca, Plc.
  14. 8.3.1 AstraZeneca, Plc. Company Information
  15. 8.3.2 AstraZeneca, Plc. Business Overview
  16. 8.3.3 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  18. 8.3.5 AstraZeneca, Plc. Recent Developments
  19. 8.4 Medtronic
  20. 8.4.1 Medtronic Company Information
  21. 8.4.2 Medtronic Business Overview
  22. 8.4.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  24. 8.4.5 Medtronic Recent Developments
  25. 8.5 Takeda Pharmaceutical Company Limited
  26. 8.5.1 Takeda Pharmaceutical Company Limited Company Information
  27. 8.5.2 Takeda Pharmaceutical Company Limited Business Overview
  28. 8.5.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  30. 8.5.5 Takeda Pharmaceutical Company Limited Recent Developments
  31. 8.6 The Kroger Co.
  32. 8.6.1 The Kroger Co. Company Information
  33. 8.6.2 The Kroger Co. Business Overview
  34. 8.6.3 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  36. 8.6.5 The Kroger Co. Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Novartis AG
  56. 8.10.1 Novartis AG Company Information
  57. 8.10.2 Novartis AG Business Overview
  58. 8.10.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  60. 8.10.5 Novartis AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gastro Esophageal Reflux Disease (GERD) Drug Value Chain Analysis
  2. 9.1.1 Gastro Esophageal Reflux Disease (GERD) Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gastro Esophageal Reflux Disease (GERD) Drug Production Mode & Process
  6. 9.2 Gastro Esophageal Reflux Disease (GERD) Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors
  9. 9.2.3 Gastro Esophageal Reflux Disease (GERD) Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst